Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 8, 2013 - Issue
Submit an article Journal homepage
61
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Drugs potentially affecting the extent of airways reversibility on pulmonary function testing are frequently consumed despite guidelines

Terry E Jones1 Pharmacy Department, The Queen Elizabeth Hospital, Woodville South, SACorrespondence[email protected]
,
AnneMarie Southcott2 Respiratory and Sleep Medicine, Western Health, Footscray, VIC, Australia
&
Sean Homan3 Respiratory Unit, The Queen Elizabeth Hospital, Woodville South, SA, Australia
Pages 383-388 | Published online: 09 Aug 2013

References

  • MillerMHankinsonJBrusascoVStandardisation of spirometryEur Resp J200526319338
  • EverlyMHeatonPCCluxtonRJβ-blocker underuse in secondary prevention of myocardial infarctionAnn Pharmacother20043828629314742768
  • SalpeterSROrmistonTMSalpeterEECardioselective β-blockers in patients with reactive airway disease: a meta-analysisAnn Intern Med200213771572512416945
  • GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med19983394894979709041
  • ChenJRadfordMJWangYMarciniakTAKrumholzHMEffectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthmaJAMA20013719501956
  • EgredMShawSMohammedBWaittPRodriguesEUnder-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary diseaseQJM20059849349715955798
  • OlenchockBAFonarowGGPanWCurrent use of beta blockers in patients with reactive airways disease who are hospitalised with acute coronary syndromesAm J Cardiol200910329530019166678
  • ShortPMLipworthSIWElderDHJSchembriSLipworthBJEffect of β blockers in treatment of chronic obstructive disease: a retrospective cohort studyBMJ2001342
  • RuttenFHZuithoffNPAHakEβ-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med201017088088720498416
  • LingYSaleemWSheeCDConcomitant use of β-blockers and β2-agonistsEur Respir J2008490590618378787
  • BorrillZLHoughtonCMWoodcockAAVestboJSinghDMeasuring bronchodilation in COPD clinical trialsBr J Clin Pharmacol20045937938415801931
  • HoughtonCMWoodcockAASinghDA comparison of lung function methods for assessing dose-response effects of salbutamolBr J Clin Pharmacol20045813414115255795
  • HadcroftJCalverleyPMAAlternative methods for assessing bronchodilator reversibility in chronic obstructive diseaseThorax20015671372011514693
  • TashkinDPCelliBSennSA 4-yr trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J20083174275018256071
  • SorianoJBManninoDMReversing concepts on COPD irreversibilityEur J Resp J200831695696

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.